Scarica l'app Stockscreener
11.18
1.27%
0.14
Dopo l'orario di chiusura:
11.18
Benitec Biopharma Inc Borsa (BNTC) Ultime notizie
Is Benitec Biopharma Inc. a good long term investmentUnrivaled growth potential - jammulinksnews.com
What drives Benitec Biopharma Inc. stock priceMarket-crushing stock picks - PrintWeekIndia
What analysts say about Benitec Biopharma Inc. stockFree Stock Market Mentorship - Autocar Professional
(BNTC) Investment Report - news.stocktradersdaily.com
Benitec Biopharma Inc. Stock Analysis and ForecastOutstanding capital appreciation - jammulinksnews.com
Does Benitec Biopharma Inc. stock pay reliable dividendsFree Investment Community - Newser
Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Recommendation of “Buy” by Analysts - Defense World
What analysts say about Benitec Biopharma Inc. stock outlookSmart High Yield Swing Trades - Newser
Why Benitec Biopharma Inc. stock attracts strong analyst attentionLong Term Safe Yield Focus - beatles.ru
Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise amid trial progress By Investing.com - Investing.com South Africa
How Benitec Biopharma Inc. stock performs during market volatilityFree Stock Market Entry & Exit Signals - Newser
What makes Benitec Biopharma Inc. stock price move sharplyTriple Digit Return Forecasts - Newser
Citizens JMP Reaffirms Their Buy Rating on Benitec Biopharma (BNTC) - The Globe and Mail
Benitec BioPharma stock maintains Market Outperform rating at JMP By Investing.com - Investing.com Canada
Benitec completes first cohort in gene therapy trial, advances to next phase By Investing.com - Investing.com South Africa
When the Price of (BNTC) Talks, People Listen - news.stocktradersdaily.com
Benitec Biopharma Advances BB-301 Clinical Study - TipRanks
Benitec Biopharma Provides Operational Updates - GlobeNewswire
Benitec Biopharma Inc. Provides Operational Updates - MarketScreener
Benitec Biopharma (BNTC) Moves Forward with Clinical Study Enrollment | BNTC Stock News - GuruFocus
Benitec completes first cohort in gene therapy trial, advances to next phase - Investing.com
Benitec's BB-301 Gene Therapy Achieves Key Safety Milestone, Phase 1b/2a Trial Set to Expand - Stock Titan
Benitec Biopharma (NASDAQ:BNTC) Now Covered by Analysts at TD Cowen - Defense World
Benitec Biopharma Inc.(NasdaqCM: BNTC) added to Russell 3000 Index - MarketScreener
Benitec Biopharma Inc.(NasdaqCM: BNTC) added to Russell 3000 Growth Index - MarketScreener
Benitec Biopharma(BNTC) Plunges 8.10% on Earnings Concerns - AInvest
Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Trading (BNTC) With Integrated Risk Controls - news.stocktradersdaily.com
GAMMA Investing LLC Grows Stake in Benitec Biopharma Inc. (NASDAQ:BNTC) - Defense World
Benitec Biopharma (BNTC) is on the Move, Here's Why the Trend Could be Sustainable - Nasdaq
(BNTC) Trading Report - news.stocktradersdaily.com
Wall Street Analysts See a 65.98% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? - Yahoo Finance
Benitec Biopharma Inc. (NASDAQ:BNTC) Position Boosted by Ameriprise Financial Inc. - Defense World
Is Benitec Biopharma (BNTC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Form 424B3 Benitec Biopharma Inc. - StreetInsider
Northern Trust Corp Grows Stock Holdings in Benitec Biopharma Inc. (NASDAQ:BNTC) - Defense World
Recent Price Trend in Benitec Biopharma (BNTC) is Your Friend, Here's Why - Yahoo Finance
0.87%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):